Pseudomonas exotoxin: recombinant conjugates as therapeutic agents.
FitzGerald
D J
DJ
Department of Health and Human Services, National Cancer Institute, Bethesda, Maryland 20892.
Pastan
I
I
D036002:ADP Ribose Transferases; D000818:Animals; D001427:Bacterial Toxins / Q000378:metabolism / Q000627:therapeutic use*; D005098:Exotoxins / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D000922:Immunotoxins / Q000378:metabolism / Q000627:therapeutic use*; D011550:Pseudomonas aeruginosa; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A
D036002:ADP Ribose Transferases; D001427:Bacterial Toxins; D005098:Exotoxins; D000922:Immunotoxins; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A